LX107
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LX107, covering 2026-03-10 to 2026-03-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LX107 Gene Therapy in AIPL1-IRD Patients [EARLY_Phase 1]